Glaukos PE Ratio 2014-2023 | GKOS
Current and historical p/e ratio for Glaukos (GKOS) from 2014 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Glaukos PE ratio as of April 22, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Glaukos PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-04-22 | 98.95 | 0.00 | |
2023-12-31 | 79.49 | $-2.78 | 0.00 |
2023-09-30 | 75.25 | $-2.69 | 0.00 |
2023-06-30 | 71.21 | $-2.64 | 0.00 |
2023-03-31 | 50.10 | $-2.92 | 0.00 |
2022-12-31 | 43.68 | $-2.09 | 0.00 |
2022-09-30 | 53.24 | $-1.90 | 0.00 |
2022-06-30 | 45.42 | $-1.19 | 0.00 |
2022-03-31 | 57.82 | $-0.61 | 0.00 |
2021-12-31 | 44.44 | $-1.08 | 0.00 |
2021-09-30 | 48.17 | $-0.85 | 0.00 |
2021-06-30 | 84.83 | $-1.33 | 0.00 |
2021-03-31 | 83.93 | $-1.85 | 0.00 |
2020-12-31 | 75.26 | $-2.73 | 0.00 |
2020-09-30 | 49.52 | $-1.65 | 0.00 |
2020-06-30 | 38.42 | $-1.67 | 0.00 |
2020-03-31 | 30.86 | $-0.94 | 0.00 |
2019-12-31 | 54.47 | $0.26 | 209.50 |
2019-09-30 | 62.51 | $-0.54 | 0.00 |
2019-06-30 | 75.40 | $-0.36 | 0.00 |
2019-03-31 | 78.37 | $-0.34 | 0.00 |
2018-12-31 | 56.17 | $-0.38 | 0.00 |
2018-09-30 | 64.90 | $-0.39 | 0.00 |
2018-06-30 | 40.64 | $-0.16 | 0.00 |
2018-03-31 | 30.83 | $-0.11 | 0.00 |
2017-12-31 | 25.65 | $-0.01 | 0.00 |
2017-09-30 | 33.00 | $-0.04 | 0.00 |
2017-06-30 | 41.47 | $-0.05 | 0.00 |
2017-03-31 | 51.30 | $0.11 | 466.36 |
2016-12-31 | 34.30 | $0.12 | 285.83 |
2016-09-30 | 37.74 | $0.05 | 754.80 |
2016-06-30 | 29.16 | $-0.05 | 0.00 |
2016-03-31 | 16.86 | $-1.41 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $4.966B | $0.315B |
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $209.324B | 25.46 |
Intuitive Surgical (ISRG) | United States | $130.862B | 78.83 |
Edwards Lifesciences (EW) | United States | $52.344B | 34.65 |
DexCom (DXCM) | United States | $50.703B | 87.10 |
IQVIA Holdings (IQV) | United States | $41.988B | 24.90 |
IDEXX Laboratories (IDXX) | United States | $39.830B | 47.62 |
Alcon (ALC) | Switzerland | $39.749B | 29.31 |
STERIS (STE) | Ireland | $19.852B | 23.50 |
Hologic (HOLX) | United States | $17.891B | 19.75 |
Waters (WAT) | United States | $17.747B | 25.47 |
SONOVA HOLDING (SONVY) | Switzerland | $16.624B | 0.00 |
ShockWave Medical (SWAV) | United States | $12.289B | 84.91 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $12.059B | 14.89 |
Sysmex ADR (SSMXY) | Japan | $9.956B | 31.22 |
Teleflex (TFX) | United States | $9.763B | 15.33 |
Penumbra (PEN) | United States | $7.857B | 97.13 |
Masimo (MASI) | United States | $7.107B | 39.86 |
Globus Medical (GMED) | United States | $6.938B | 22.00 |
Integer Holdings (ITGR) | United States | $3.908B | 24.98 |
LivaNova (LIVN) | United Kingdom | $2.914B | 19.22 |
TransMedics (TMDX) | United States | $2.830B | 0.00 |
Elekta AB (EKTAY) | Sweden | $2.660B | 18.25 |
PROCEPT BioRobotics (PRCT) | United States | $2.609B | 0.00 |
Nihon Kohden (NHNKY) | Japan | $2.368B | 20.03 |
Integra LifeSciences Holdings (IART) | United States | $2.278B | 9.35 |
Inari Medical (NARI) | United States | $2.198B | 379.30 |
Tandem Diabetes Care (TNDM) | United States | $2.049B | 0.00 |
RxSight (RXST) | United States | $1.936B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.765B | 0.00 |
Veracyte (VCYT) | United States | $1.490B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.876B | 16.20 |
OPKO Health (OPK) | United States | $0.857B | 0.00 |
Artivion (AORT) | United States | $0.837B | 96.76 |
Paragon 28 (FNA) | United States | $0.812B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.718B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.685B | 0.00 |
Silk Road Medical (SILK) | United States | $0.682B | 0.00 |
SiBone (SIBN) | United States | $0.639B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.552B | 18.73 |
IRadimed (IRMD) | United States | $0.536B | 31.15 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.489B | 0.00 |
Nevro (NVRO) | United States | $0.450B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.418B | 0.00 |
Pulse Biosciences (PLSE) | United States | $0.378B | 0.00 |
NeuroPace (NPCE) | United States | $0.368B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.348B | 11.72 |
CVRx (CVRX) | United States | $0.317B | 0.00 |
AxoGen (AXGN) | United States | $0.300B | 0.00 |
Sight Sciences (SGHT) | United States | $0.266B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.265B | 0.00 |
AngioDynamics (ANGO) | United States | $0.251B | 0.00 |
Accuray (ARAY) | United States | $0.215B | 0.00 |
Semler Scientific (SMLR) | United States | $0.185B | 9.95 |
908 Devices (MASS) | United States | $0.184B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.178B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.170B | 0.00 |
Inogen (INGN) | United States | $0.158B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.149B | 0.00 |
Delcath Systems (DCTH) | United States | $0.140B | 0.00 |
Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
Neuronetics (STIM) | United States | $0.112B | 0.00 |
Envoy Medical (COCH) | United States | $0.099B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.097B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.086B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.070B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.065B | 0.00 |
Hyperfine (HYPR) | United States | $0.061B | 0.00 |
SEP Acquisition (SEPA) | United States | $0.059B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.057B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.056B | 113.00 |
Vasomedical (VASO) | United States | $0.051B | 9.17 |
Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
InspireMD (NSPR) | Israel | $0.045B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.043B | 0.00 |
ReWalk Robotics (LFWD) | Israel | $0.042B | 0.00 |
DarioHealth (DRIO) | United States | $0.039B | 0.00 |
LENSAR (LNSR) | United States | $0.037B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.037B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.036B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
Precision Optics (POCI) | United States | $0.033B | 0.00 |
Spectral AI (MDAI) | United States | $0.032B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.024B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.019B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.017B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.017B | 0.00 |
PAVmed (PAVM) | United States | $0.017B | 0.00 |
NexGel (NXGL) | United States | $0.014B | 0.00 |
Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
Avinger (AVGR) | United States | $0.006B | 0.00 |
Venus Concept (VERO) | Canada | $0.005B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Tenon Medical (TNON) | United States | $0.003B | 0.00 |
Dynatronics (DYNT) | United States | $0.003B | 0.00 |
Nuwellis (NUWE) | United States | $0.002B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |